SunLink Health Systems (SunLink Health Systems) Research & Development : $0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 1990. Start your Free Trial

What is SunLink Health Systems Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. SunLink Health Systems's Research & Development for the three months ended in Dec. 2023 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil.

SunLink Health Systems Research & Development Historical Data

The historical data trend for SunLink Health Systems's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SunLink Health Systems Research & Development Chart

SunLink Health Systems Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Research & Development

Get a 7-Day Free Trial

SunLink Health Systems Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Research & Development	Get a 7-Day Free Trial															-	-	-	-	-

SunLink Health Systems Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

SunLink Health Systems (AMEX:SSY) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

SunLink Health Systems Research & Development Related Terms

Thank you for viewing the detailed overview of SunLink Health Systems's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

SunLink Health Systems (SunLink Health Systems) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SunLink Health Systems Inc (AMEX:SSY) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

N/A

Address

900 Circle 75 Parkway, Suite 690, Atlanta, GA, USA, 30339

Website

http://www.sunlinkhealth.com

SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operates nearly 80-licensed-bed, acute care hospitals, which includes more than 18-bed geriatric psychology unit, and over 60-bed nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.

Executives

Howard E Turner	director	135 PROVIDENCE OAKS POINTE, MILTON GA 30004
Thornton Robert M Jr	director, officer: CEO & Chairman	900 CIRCLE 75 PARKWAY, SUITE 690, ATLANTA GA 30339
C Michael Ford	director	310 NORRIS STREET, ST. MARYS GA 31558
Mills Christopher H B	director	6 STRATTON STREET, MAYFAIR, LONDON X0 W1J 8LD
Steven J Baileys	director	30691 HUNT CLUB DRIVE, SAN JUAN CAPISTRANO CA 92675
Sheila G. Brockman	officer: CEO So Health Corp of Houston	900 CIRCLE 75 PARKWAY, SUITE 690, ATLANTA GA 30339
Mark J Stockslager	officer: Corporate Controller and PAO	900 CIRCLE 75 PARKWAY STE. 690, ATLANTA GA 30339
Karen B Brenner	director	P.O. BOX 9109, NEWPORT BEACH CA 92658
Gene E Burleson	director	320 ARGONNE DR, ATLANTA GA 30305-2814
A Ronald Turner	officer: Chief Operating Officer	900 CIRCLE 75 PARKWAY, SUITE 1120, ATLANTA GA 30339
Harry R Alvis	officer: Chief Operating Officer	900 CIRCLE 75 PARKWAY STE. 1120, ATLANTA GA 30339
George D. Shaunnessy	other: Pres/CEO Sunlink Homecare Svcs	900 CIRCLE 75 PARKWAY, SUITE 1120, ATLANTA GA 30339
Jack M. Spurr	officer: VP, Hospital Financial Ops.	900 CIRCLE 75 PARKWAY, SUITE 1120, ATLANTA GA 30339
Michael William Hall	director	3406 RAVENWOOD LANE, MIRAMAR BEACH FL 32550
North Atlantic Value Llp	10 percent owner	RYDER COURT, 14 RYDER ST., LONDON A1 00000